Complete Catalog — 92 Compounds
AllPeptides
92 compounds across every goal — CoA-verified on every batch, from skin collagen to telomere extension to GLP-1 fat-loss protocols.
Showing 26 peptides · Recovery & Healing
Thymosin Alpha-1
Acetylated N-terminal fragment of prothymosin-α, studied for T-cell maturation and innate-immune modulation. Available in 5 mg and 10 mg research vials.
VIP (Vasoactive Intestinal Peptide)
Vasoactive intestinal peptide — 28-residue neuropeptide studied for smooth-muscle relaxation and mast-cell stabilization research. Available in 5 mg and 10 mg.
KPV
Lysine-proline-valine — the C-terminal tripeptide of α-MSH studied for anti-inflammatory and gut-barrier endpoints. Available in 5 mg and 10 mg.
BPC-157 10mg
A 15-amino-acid sequence isolated from body protection compound found in gastric juice. Investigated extensively for tendon, ligament, and intestinal lining repair — this 10mg vial is the common research protocol size.
TB-500 10mg
Synthetic fragment of Thymosin Beta-4 — a 43-amino-acid protein that sequesters G-actin and drives cell migration to sites of injury. Long half-life permits a twice-weekly loading cadence, very different from daily BPC-157.
ARA-290 10mg
Eleven-amino-acid fragment of erythropoietin (sequence QEQLERALNSS) that activates the innate repair receptor without raising hematocrit. Originally developed by Araim Pharmaceuticals for sarcoidosis neuropathy.
BPC-157 Capsules 500mcg x60
Sixty oral capsules at 500mcg each — 30mg total. Uses BPC-157's unusual oral stability (most peptides are destroyed in the stomach; this pentadecapeptide survives) to deliver gut-focused research without an injection.
Bacteriostatic Water 30mL
Sterile water with 0.9% benzyl alcohol as a bacteriostatic preservative — the solvent used to reconstitute every lyophilized peptide in your protocol. One 30mL vial handles roughly 15–30 reconstitutions, depending on peptide volume.
Bacteriostatic Water USP 30mL
USP-grade sterile water with 0.9% benzyl alcohol — the pharmacopeia-verified reconstitution solvent. Identical function to standard bacteriostatic water but manufactured and tested against United States Pharmacopeia monograph standards.
Bronchogen 20mg
Bronchogen is a Khavinson-class short peptide bioregulator positioned for bronchial epithelium research — one of the sixteen tissue-targeted oligopeptides developed at the St. Petersburg Institute of Bioregulation and Gerontology from the original lung-extract drug Bronchalamin.
Cardiogen 20mg
Cardiogen — the myocardial entry in Khavinson's bioregulator series — is a short peptide (commonly written as Ala-Glu-Asp-Arg) extracted from work on calf cardiac tissue and taken as a synthetic successor to the heart-derived drug Kardiolin.
Cartalax 20mg
Cartalax is the cartilage-positioned Khavinson tetrapeptide (Ala-Glu-Asp-Leu, AEDL), researched as a chondrocyte-selective successor to the joint-tissue extract Cartalin and typically paired with Pinealon in age-related musculoskeletal work.
Chonluten 20mg
Chonluten is a Glu-Asp-Gly (EDG) tripeptide in the Khavinson series positioned for bronchial and gastric mucosal research — and one of the few in the series where some Western investigators have replicated mucin- and proliferation-marker endpoints.
Cortagen 20mg
Cortagen is a Khavinson tetrapeptide positioned for cerebral-cortex research — the neurological companion to Epitalon, derived from work on calf cortical tissue extract (Cortexin) and intended as its synthetic successor.
Crystagen 20mg
Crystagen is the second thymic peptide in the Khavinson series — a Glu-Asp-Pro (EDP) tripeptide positioned alongside Thymogen and Vilon as one of three immune-system bioregulators the framework assigns to thymic function in ageing.
LL-37 10mg
The body's only human cathelicidin-derived antimicrobial peptide — 37 residues of broad-spectrum innate immunity. Disrupts bacterial membranes directly while also signalling to human immune cells as a cytokine-like alarm molecule.
Livagen 20mg
Livagen is a Lys-Glu-Asp-Ala (KEDA) tetrapeptide in the Khavinson series targeted to hepatic tissue — a synthetic successor to the calf-liver peptide extract Epithalon, positioned for research on hepatocyte function in ageing.
Ovagen 20mg
Ovagen is one of the more confusingly named entries in the Khavinson series: despite its name it is positioned for hepatic and gastrointestinal research rather than ovarian tissue, with the tripeptide sequence Glu-Asp-Leu (EDL) assigned to upper-GI mucosal cells.
Pancragen 20mg
Pancragen is the Khavinson series' pancreatic bioregulator — a Lys-Glu-Asp-Trp (KEDW) tetrapeptide positioned for research on islet and exocrine pancreatic cells in ageing, paired canonically with Livagen for the hepatic/pancreatic metabolic axis.
Prostamax 20mg
Prostamax is the prostate-positioned synthetic tetrapeptide in the Khavinson series, successor to the earlier bovine-prostate extract Prostatilen — a drug with a substantial Soviet-era urology track record that informs how the synthetic representative is studied today.
Testagen 20mg
Testagen is the Khavinson testicular-tissue bioregulator — a short peptide (Lys-Glu-Asp-Gly, KEDG, in most Khavinson references) positioned for Leydig and seminiferous tubule research rather than as a testosterone-elevating peptide.
Thymogen 20mg
Thymogen is the founder peptide of the Khavinson synthetic bioregulator series — a Glu-Trp (EW) dipeptide, the shortest in the catalogue, derived from the Soviet-era thymic tissue drug Thymalin and with a longer Russian clinical track record than any other entry in this class.
Thymulin 10mg
Thymulin is a different kind of thymic peptide from the Khavinson series — a nine-residue zinc-binding nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) isolated by Bach's group in Paris in the 1970s, historically known as “serum thymic factor” or Facteur Thymique Sérique (FTS).
Vesilute 20mg
Vesilute is the urinary-tract bioregulator in the Khavinson series — positioned for bladder detrusor and urothelial research, a narrower and less-studied tissue slot than most of the catalogue occupies.
Vesugen 20mg
Vesugen is the vascular-endothelium bioregulator in the Khavinson series — a Lys-Glu-Asp (KED) tripeptide positioned for research on endothelial ageing and vessel-wall cell turnover, paired canonically with Cardiogen in cardiovascular research protocols.
Vilon 20mg
Vilon is a Lys-Glu (KE) dipeptide — the second minimal peptide to emerge from the Khavinson program — specifically studied across a cluster of aged-rodent lifespan-extension experiments that remain some of the most-cited data in the series.
Premium Peptide Catalog
Shop the Complete Catalog
92 premium compounds for looks maxing, body composition, longevity, and peak performance — pharmaceutical-grade, certificate of analysis verified on every batch.
Shop Now
